Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Predicting success: optimizing phase II ALS trials for the transition to phase III.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
Predicting success: optimizing phase II ALS trials for the transition to phase III.
Predicting success: optimizing phase II ALS trials for the transition to phase III. Amyotroph Lateral Scler Frontotemporal Degener. 2014 Mar; 15(1-2):1-8.
View in:
PubMed
subject areas
Amyotrophic Lateral Sclerosis
Clinical Trials, Phase II as Topic
Clinical Trials, Phase III as Topic
Humans
Predictive Value of Tests
Randomized Controlled Trials as Topic
Treatment Outcome
authors with profiles
Merit Ester Cudkowicz, M.D.
James Dale Berry, M.D.